Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea introduces monthly reporting requirements on drug supplies

This article was originally published in SRA

Executive Summary

A new regulation in South Korea requires pharmaceutical manufacturers, importers and wholesalers (ie suppliers) to report to the Korea Pharmaceutical Information Service the details of their transactions for the supply of medicines - including unit price and quantities - within one month of the products being distributed1. The rule implements amendments to the Pharmaceutical Affairs Law and is expected to contribute to the reduction of medical expenditure, as well as to the establishment of transparent transaction practices by minimising counterfeits, “non-invoice” deals and false claims of reimbursement for expensive drugs.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS114198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel